  See all
 |
Articles: Rheumatoid Arthritis |
Prior Articles
Decreased RAGE expression in peripheral blood mononuclear cells of patients with rheumatoid arthritis
Clinical and Experimental Rheumatology Online, 07/29/09
CCL20 produced in the cytokine network of rheumatoid arthritis recruits CCR6+ mononuclear cells and enhances the production of IL-6
Cytokine, 07/29/09 Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: Synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies
Arthritis Research & Therapy, 07/28/09
Free full text
Markers of B lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort
Arthritis Research & Therapy, 07/28/09
Free full text
A mismatch between self-reported physical work load and the HAQ: early identification of rheumatoid arthritis patients at risk for loss of work productivity
Clinical and Experimental Rheumatology Online, 07/28/09 The prevalence of musculoskeletal complaints in a rural area in Iran: a WHO-ILAR COPCORD study (stage 1, rural study) in Iran
Clinical Rheumatology, 07/28/09
Exclusive Author Commentary Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to Disease Activity Score-28
Autoimmunity, 07/27/09 Systemic nonarticular manifestations of rheumatoid arthritis: Focus on inflammatory mechanisms
Seminars in Arthritis and Rheumatism, 07/24/09 Clinical and high resolution computed tomography characteristics of patients with rheumatoid arthritis lung disease
International Journal of Rheumatic Diseases, 07/24/09 A pharmacodynamic markov mixed-effects model for determining the effect of exposure to certolizumab pegol on the ACR20 score in patients with rheumatoid arthritis
Clinical Pharmacology & Therapeutics, 07/24/09 Obstacles to action in arthritis: A community case-control study
International Journal of Rheumatic Diseases, 07/24/09 The risk of infections with biologic therapies for rheumatoid arthritis
Seminars in Arthritis and Rheumatism, 07/23/09 Changes in the rates of joint surgery among patients with rheumatoid arthritis in California, 1983-2007
Annals of Rheumatic Diseases, 07/23/09 Medico-economic evaluation of infliximab in rheumatoid arthritis—prospective French study of a cohort of 635 patients monitored for two years
Rheumatology, 07/23/09 Wnt pathway and IL-17: Novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis
Seminars in Arthritis and Rheumatism, 07/23/09 Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): A multicentre, randomised, double-blind, placebo-controlled, phase III trial
The Lancet, 07/22/09 Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy (the CAMERA study)
Annals of Rheumatic Diseases, 07/22/09 Clinical response, pharmacokinetics, development of human anti-chimeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis
Annals of Rheumatic Diseases, 07/22/09 Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-TNF naive patients: A cohort study
Annals of Rheumatic Diseases, 07/22/09 Improved pain, physical functioning, and health status in rheumatoid arthritis patients treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: Results from a randomized, double-blind, placebo-controlled trial
Annals of Rheumatic Diseases, 07/22/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatology
more...
|
250 Available Pages
|
|
